Acceleration in technology development in the healthcare sector has tremendously increased in last few years. Advancement in technology of medical devices supports painless and uncomplicated treatment during disease management. Moreover, innovation and upgrading in medical devices assist in disease diagnosis's precise and rapid results. In addition, innovation in medical devices provides the cost-effectiveness of technology-based therapeutic tools during disease treatment.
Access Full Report @ https://www.databridgemarketresearch.com/jp/reports/global-medical-device-testing-market
The global medical device testing market is expected to reach USD 8,423.14 million by 2029 from USD 3,832.27 million in 2021, growing at a CAGR of 10.8% in the forecast period of 2022 to 2029. The rising need for global verification and validation of medical devices has enhanced the market's growth. The rising healthcare expenditure for better health services also contributes to the market's growth. Some of the major market players focus on various service launches and approvals during this crucial period.
The rising need for verification & validation of medical devices across the world will drive the market's growth rate
Medical devices are also becoming smaller and more complex in design using advanced, engineered plastics. This makes the process of validation and verification (V&V) all the more important. This results in better repeatability, fewer mistakes, less rework and redesign, faster time to market, improved competitiveness, and lower production costs. Additionally, increasing standards and regulations about medical device validation and verification services are anticipated to drive the growth of the medical device testing market.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Service Type (Testing Services, Inspection Service and Certification Services), Testing Type (Physical Testing, Chemical/Biological Testing, Cybersecurity Testing, Microbiology and Sterility Testing and Others), Phase (Preclinical and Clinical), Sourcing Type (In-House and Outsourced), Device Class (Class I, Class II and Class III), Product (Active Implant Medical Device, Active Medical Device, Non-Active Medical Device, In-vitro Diagnostics Medical Device, Ophthalmic Medical Device, Orthopedic and Dental Medical Device, Vascular Medical Device and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
SGS (Switzerland), Eurofins Scientific (U.K.), Bureau Veritas (U.K.), Intertek (U.K.), TÜV SÜD (U.K.), DEKRA (U.K.), BSI (U.K.), TÜV Rheinland (U.K.), Elements Material Technology (U.K.), Envigo (U.S.), Avomeen Analytical Services (U.S.), Gateway Analytical (U.S.), Medistri SA (Switzerland), North American Science Associates (U.S.), Pace Analytical Services (U.S.), Wuxi Apptec (China), Toxikon (U.S.), Charles River Laboratories (U.S.), Medical Device Testing services (U.S.), Source Bioscience (U.K.), NSF International (U.S.), BDC laboratories (U.S.) and Surpass (U.S.) among others.
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global medical device testing market is categorized into six notable segments such as service type, testing type, phase, sourcing type, device class, and product.
- On the basis of service type, the global medical device testing market is segmented into testing services, inspection services, and certification services. In 2022, testing services segment is expected to dominate the global medical device testing market with 69.00% market share as this type of service is more prevalent in various regions
- On the basis of testing type, the global medical device testing market is segmented into physical testing, chemical/biological testing, cybersecurity testing, microbiology and sterility testing and others. In 2022, the chemical/biological testing segment is expected to dominate the global medical device testing market with a 36.10% market share. This type of testing is very important for the medical devices to be marketed.
- On the basis of phase, the global medical device testing market is segmented into preclinical and clinical. In 2022, the preclinical segment is expected to dominate the global medical device testing market with 79.52% market share as this phase is highly important for medical device testing.
- On the basis of sourcing type, the global medical device testing market is segmented into in-house and outsourced. In 2022, outsourced segment is expected to dominate the global medical device testing market with 73.53% market share as it is a less expensive type of sourcing present in the market which the manufacturers highly prefer.
- On the basis of device class, the global medical device testing market is segmented into class I, class II and class III. In 2022, class I segment is expected to dominate the global medical device testing market with 42.54% market share due to increasing R&D activities for class I medical devices.
The class I segment will dominate the device class segment of the medical device testing market
The class I segment will emerge as the dominating segment device class segment. This is because of the growing awareness about the systems in the market, especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
- On the basis of product, the global medical device testing market is segmented into active implant medical device, active medical device, non-active medical device, in-vitro diagnostics medical device, opthalmic medical device, orthopedic and dental medical device, vascular medical device, and others. In 2022, the non-active medical device segment is expected to dominate the global medical device testing market with 29.02% market share. This type of medical device is highly used in the market; hence, these products need to be tested before coming into the market.
The non-active medical device segment will dominate the product segment of the medical device testing market
The non-active medical device segment will emerge as the dominating segment under product with approximately 29.00% market share. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the IT industry all around the globe will further bolster the growth of this segment.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in medical device testing market: SGS (Switzerland), Eurofins Scientific (U.K.), Bureau Veritas (U.K.), Intertek (U.K.), TÜV SÜD (U.K.), DEKRA (U.K.), BSI (U.K.), TÜV Rheinland (U.K.), Elements Material Technology (U.K.), Envigo (U.S.), Avomeen Analytical Services (U.S.), Gateway Analytical (U.S.), Medistri SA (Switzerland), North American Science Associates (U.S.), Pace Analytical Services (U.S.), Wuxi Apptec (China), Toxikon (U.S.), Charles River Laboratories (U.S.), Medical Device Testing services (U.S.), Source Bioscience (U.K.), NSF International (U.S.), BDC laboratories (U.S.) and Surpass (U.S.).
Market Development
- In April 2021, TÜV SÜD announced that it had presented itself at Medtec LIVE to exhibit its ability to be a one-stop shop for medical device testing. The company's services covered electrical and functional safety testing, cyber security and software, EMC, and biocompatibility. The experts from TÜV SÜD were featured in the program of the online trade show and congress with various talks, a live hack and an elevator pitch
- In June 2020, Intertek announced the expansion of its personal protective equipment services, including precertification testing of N95 respirators to requirements set by the National Institute for Occupational Safety and Health (NIOSH). The new services are the result of the successful accreditation to NIOSH Standard Test Protocols, under ISO 17025. With these new services, Intertek also expands upon its solutions and resources to support customers and the global community during the COVID-19 pandemic.
Regional Analysis
Geographically, the countries covered in the medical device testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in medical device testing market during the forecast period 2022 - 2029
North America dominates the medical device testing market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising need for verifying and validating medical devices in the region, and rapid research development is boosting the market.
Asia-Pacific is estimated to be the fastest growing region in medical device testing market the forecast period 2022 - 2029
Asia-Pacific is likely to be the fastest-growing region in the global market owing to the developing healthcare infrastructure.
COVID-19 Impact
COVID-19 has positively affected the market. Medical devices such as MRI scanners, ventilators, and others have increased in those years. Hence the use of various devices has widely increased in the 'world's population. Thus, the pandemic has effected positively on this testing market.
For more detailed information about the medical device testing on market report, click here – https://www.databridgemarketresearch.com/jp/reports/global-medical-device-testing-market
